Regular Article
Inhibition of Platelet Aggregation by the Recombinant Cysteine-Rich Domain of the Hemorrhagic Snake Venom Metalloproteinase, Atrolysin A

https://doi.org/10.1006/abbi.1999.1517Get rights and content

Abstract

The P-III class of venom metalloproteinases has, in addition to the proteinase domain, a disintegrin-like domain and a cysteine-rich domain. Recent evidence has shown that the nonproteinase domains of the P-III class of hemorrhagic metalloproteinases function in the inhibition of platelet aggregation by blocking essential procoagulant integrins on platelets. A specific role for the highly conserved cysteine-rich domain has yet to be described. In this study, we expressed the cysteine-rich domain from the hemorrhagic metalloproteinase atrolysin A and demonstrated its ability to inhibit collagen-stimulated platelet aggregation. Additionally, the cysteine-rich domain was shown to interact with MG-63 cells to inhibit adhesion to collagen I. These data suggest a functional role for the cysteine-rich domain of the P-III toxins in the observed coagulopathy by targeting the toxin to platelets and inhibiting collagen-stimulated platelet aggregation. These characteristics may function to synergistically increase the hemorrhagic effect of the toxins.

References (26)

  • J.B. Bjarnason et al.
  • T.G. Wolfsberg et al.

    Dev. Biol.

    (1995)
  • L.A. Hite et al.

    Arch. Biochem. Biophys.

    (1994)
  • E.N. Baramova et al.

    Arch. Biochem. Biophys.

    (1989)
  • L.-G. Jia et al.

    J. Biol. Chem.

    (1997)
  • M. De Luca et al.

    Biochem. Biophys. Res. Commun.

    (1995)
  • Y. Usami et al.

    Biochem. Biophys. Res. Commun.

    (1994)
  • K. Shimokawa et al.

    Arch. Biochem. Biophys.

    (1997)
  • R.M. Scarborough et al.

    J. Biol. Chem.

    (1991)
  • R.M. Scarborough et al.

    J. Biol. Chem.

    (1993)
  • A.S. Kamiguti et al.

    Biochim. Biophys. Acta

    (1997)
  • W.N. Burnette

    Anal. Biochem.

    (1981)
  • Cited by (69)

    • Cysteine as a potential anti-amyloidogenic agent with protective ability against amyloid induced cytotoxicity

      2017, International Journal of Biological Macromolecules
      Citation Excerpt :

      Further, side chains of cysteine has been shown to stabilize hydrophobic interactions and also tend to associate with hydrophobic regions of proteins [31]. Cysteine and its analogue have several applications in pharmaceutical and personal-care industries and also reported for inhibition of platelet aggregation, anti-amyloidogenic and stabilization of proteins against aggregation [32–34]. In order to get further insight into cysteine mediated aggregation inhibition of stem bromelain we evaluated the effect of cysteine by using various spectroscopic and microscopic techniques.

    • Snake venom metalloproteinases: Structure, function and relevance to the mammalian ADAM/ADAMTS family proteins

      2012, Biochimica et Biophysica Acta - Proteins and Proteomics
      Citation Excerpt :

      Alternagin-C from Bthrops alternatus has been shown to modulate α2β1 integrin-mediated cell adhesion, migration and proliferation [76]. The recombinant C domain of atrolysin A, another P-IIIa SVMP from C. atrox venom, specifically binds to collagen type-1 and the A domain of VWF, blocking collagen–VWF interactions [77,78] through binding to the VWF A-domain (VWA) [79]. The C domain of atrolysin A also binds to VWA-like domain-containing ECM proteins, such as collagen XII, collagen XIV, and matrilins 1, 3 and 4 [80].

    View all citing articles on Scopus
    1

    To whom correspondence should be addressed. Fax: (804) 982–2514. E-mail: [email protected].

    View full text